Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 12 of 128 for:    HSV-2

The VIBLOK SAfety and perFormancE Trial (SAFE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03080961
Recruitment Status : Completed
First Posted : March 15, 2017
Last Update Posted : January 9, 2018
Applied Clinical Services BV
UMC Utrecht
University of Rotterdam, The Netherlands
University of Washington
EB FlevoResearch BV
PreCare Trial & Recruitment B.V.
Information provided by (Responsible Party):
CLJI Worldwide

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : November 13, 2017
Actual Study Completion Date : November 13, 2017
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 12, 2019
May 10, 2019
2 October 2, 2019
October 24, 2019